Table: Fuji Pharmaceutical -2024/25 parent results

Fuji Pharma

11/11/2025 07:30

Nov 11 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2025    Sep 30, 2024   Sep 30, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           47.49           41.93                                
               (+13.3 pct)     (+12.0 pct)                             
  Operating        4.21            3.43                                
               (+22.6 pct)     (-0.8 pct)                              
  Recurring        3.70            3.95                                
               (-6.4 pct)      (-2.9 pct)                              
  Net              2.45            5.81                                
               (-57.8 pct)     (+86.4 pct)                             
  EPS          100.50 yen      238.94 yen                              
  Ann Div       45.50 yen       42.50 yen      47.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      21.00 yen               
  -Q4 Div       25.50 yen       22.50 yen      26.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T